Apparatus and method for preparing medicines containing radioactive substances

a technology of apparatus and radioactive substances, which is applied in the field of apparatus and a method for preparing medicines containing radioactive substances, can solve the problems of not being able to guarantee that the end product is completely cleansed of the by-products of synthesis, and the complexity of prior art apparatuses, and achieves the effect of convenient and rapid us
US20110020224A1Inactive Publication Date: 2011-01-27PHILOGEN SRL LLC
3 Cites 7 Cited by

Patent Information

Authority / Receiving Office
US · United States
Current Assignee / Owner
PHILOGEN SRL LLC
Publication Date
2011-01-27
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

An apparatus (1) for preparing medicines containing radioactive substances, more specifically injectable medicines containing beta-emitting substances, in which a radioactive element is combined, in a mixture, with a protein to be labelled using the radioactive element; the mixture is then subjected to a chromatographic separation step which separates the mixture and isolates the medicine (16).
Need to check novelty before this filing date? Find Prior Art

Description

TECHNICAL FIELD

[0001] The present invention relates to an apparatus and a method for preparing medicines containing radioactive substances, more specifically injectable medicines containing beta-emitting substances, to which the description below explicitly refers.

[0002] As is known, injectable medicines able to emit beta rays are used to eliminate tumour cells in a way that is more selective and less harmful than exposing the whole body to the rays.

[0003] The first step of preparation of such medicines involves labelling, or radio-labelling, in which the radioactive substance is incorporated in a protein to create the medicine to be injected.

[0004] The whole preparation process must take place in a rigorously sterile and shielded environment. On one hand total sterility of the drug or medicine must be guaranteed, whilst on the other hand protection from harmful exposure to beta rays is required for the operator who supervises the labelling process.

[0005] For that reason, in addition to ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More